Skip to content

Hormones and Decision Making

Hormones and Decision Making

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04865562
Enrollment
30
Registered
2021-04-29
Start date
2015-03-01
Completion date
2016-09-01
Last updated
2021-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyssocial Behavior

Brief summary

An investigation of the neuropsychological processes underlying ethical decision making.

Detailed description

This study will investigate the influence of reward sensitivity on cheating behavior via experimental manipulation of reward sensitivity using testosterone.

Interventions

1mg/0.1mL solution, to be administered intranasally

DRUG0.5% cholorbutanol, saline

125 mg 0.5% cholorbutanol, 50mg saline

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* males between 18 and 25

Exclusion criteria

* recruitment will be limited to male participants between 18 and 25 years who have no current conditions that would preclude the use of testosterone. Specific

Design outcomes

Primary

MeasureTime frameDescription
Measure of ethical behavior - Cheating rate defined as the Average number of 'heads' coin flips participants claim to have obtained90 minutesdrug administration following by behavioral outcome. Specifically, participants will have the opportunity to predict the outcome of a series of coin flips. To obtain a measure of ethical behavior, participants will have the opportunity to cheat by over-reporting their prediction accuracy.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026